C B Freeman

561 total citations
20 papers, 433 citations indexed

About

C B Freeman is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, C B Freeman has authored 20 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in C B Freeman's work include Acute Myeloid Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). C B Freeman is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). C B Freeman collaborates with scholars based in United States, United Kingdom and South Africa. C B Freeman's co-authors include R Harris, C. G. Geary, Philip A. Pizzo, Ligita Novikovs, I. W. Delamore, Ian Magrath, Jessica Walker, J. E. MacIver, Robert S. Harris and María L Santaella and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Gut and The American Journal of Cardiology.

In The Last Decade

C B Freeman

20 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C B Freeman United States 12 151 146 112 101 83 20 433
C. William Aungst United States 12 105 0.7× 114 0.8× 115 1.0× 61 0.6× 108 1.3× 17 387
Annunziata Manna Italy 10 138 0.9× 174 1.2× 228 2.0× 139 1.4× 98 1.2× 29 485
DE Stepan United States 7 113 0.7× 145 1.0× 149 1.3× 314 3.1× 93 1.1× 9 503
D. H. Cowan Canada 12 67 0.4× 118 0.8× 41 0.4× 186 1.8× 61 0.7× 32 415
M Masuda Japan 10 103 0.7× 118 0.8× 42 0.4× 173 1.7× 72 0.9× 22 382
B.M. Dale Australia 13 102 0.7× 304 2.1× 146 1.3× 371 3.7× 88 1.1× 28 716
A. Berer Austria 10 240 1.6× 99 0.7× 146 1.3× 91 0.9× 60 0.7× 13 448
Debra Frei‐Lahr United States 9 128 0.8× 128 0.9× 36 0.3× 192 1.9× 88 1.1× 18 487
Bishan S. Charak United States 9 119 0.8× 87 0.6× 46 0.4× 104 1.0× 23 0.3× 25 341
Carole Maver United States 6 141 0.9× 152 1.0× 42 0.4× 60 0.6× 21 0.3× 8 405

Countries citing papers authored by C B Freeman

Since Specialization
Citations

This map shows the geographic impact of C B Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C B Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C B Freeman more than expected).

Fields of papers citing papers by C B Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C B Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C B Freeman. The network helps show where C B Freeman may publish in the future.

Co-authorship network of co-authors of C B Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of C B Freeman. A scholar is included among the top collaborators of C B Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C B Freeman. C B Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garan, Hasan, Dennis L. Kuchar, C B Freeman, Dianne M. Finkelstein, & Jeremy N. Ruskin. (1988). Early assessment of the effect of map-guided transcatheter intracardiac electric shock on sustained ventricular tachycardia secondary to coronary artery disease. The American Journal of Cardiology. 61(13). 1018–1023. 22 indexed citations
2.
3.
Benjamin, David C., Ian Magrath, & C B Freeman. (1983). Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin.. PubMed. 71(5). 897–902. 6 indexed citations
4.
5.
Magrath, Ian T., C B Freeman, Philip A. Pizzo, et al.. (1980). Characterization of Lymphoma-Derived Cell Lines: Comparison of Cell Lines Positive and Negative for Epstein-Barr Virus Nuclear Antigen. II. Surface Markers. JNCI Journal of the National Cancer Institute. 64(3). 477–83. 71 indexed citations
6.
Magrath, Ian, Philip A. Pizzo, Jacqueline Whang‐Peng, et al.. (1980). Characterization of Lymphoma-Derived Cell Lines: Comparison of Cell Lines Positive and Negative for Epstein-Barr Virus Nuclear Antigen. I. Physical, Cytogenetic, and Growth Characteristics. JNCI Journal of the National Cancer Institute. 64(3). 465–76. 67 indexed citations
7.
Harris, R, et al.. (1980). Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia. British Journal of Cancer. 41(3). 372–377. 18 indexed citations
8.
Harris, R, C B Freeman, Geoffrey Taylor, et al.. (1978). Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions. British Journal of Cancer. 37(2). 282–288. 20 indexed citations
9.
Pizzo, Philip A., et al.. (1978). Meningeal relapse of orbital rhabdomyosarcoma. Medical and Pediatric Oncology. 4(3). 247–251. 3 indexed citations
10.
Taylor, Gillian M., et al.. (1976). Receptors for human immunoglobulin on acute myeloid leukaemic leucocytes. British Journal of Cancer. 34(4). 346–358. 9 indexed citations
11.
Taylor, Geoffrey, C B Freeman, & R Harris. (1976). Response of remission lymphocytes to autochthonous leukaemic myeloblasts. British Journal of Cancer. 33(5). 501–511. 9 indexed citations
12.
Taylor, Geoffrey, R Harris, & C B Freeman. (1976). Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia. British Journal of Cancer. 33(2). 137–143. 8 indexed citations
13.
Muldal, S., et al.. (1975). A new translocation associated with the Ph1 chromosome and an acute course of chronic granulocytic leukaemia. British Journal of Cancer. 31(3). 364–368. 16 indexed citations
14.
Freeman, C B, G M Taylor, R. J. C. Harris, et al.. (1975). Proceedings: Active immunotherapy in acute myeloid leukaemia. British Journal of Cancer. 32(2). 242–243. 1 indexed citations
15.
Taylor, G. Malcolm, et al.. (1975). Surface immunological markers in acute myeloblastic leukaemia. British Journal of Cancer. 31(2). 261–261. 17 indexed citations
16.
Hersey, Peter, I. C. M. MacLennan, Amity Campbell, R Harris, & C B Freeman. (1973). Cytotoxicity against human leukaemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts.. PubMed. 14(2). 159–67. 31 indexed citations
17.
Walker, Jessica, et al.. (1973). Immunological Studies in Acute Myeloid Leukaemia: PHA Responsiveness and Serum Inhibitory Factors. British Journal of Cancer. 27(3). 203–211. 12 indexed citations
18.
Freeman, C B, R. J. C. Harris, C. G. Geary, et al.. (1973). Active Immunotherapy Used Alone for Maintenance of Patients with Acute Myeloid Leukaemia. BMJ. 4(5892). 571–573. 45 indexed citations
19.
Walker, Jessica, C B Freeman, & Robert S. Harris. (1972). Lymphocyte reactivity in pregnancy.. BMJ. 3(5824). 469.1–469. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. William Aungst Breakdown of academic impact, for papers by Annunziata Manna Breakdown of academic impact, for papers by DE Stepan Breakdown of academic impact, for papers by D. H. Cowan Breakdown of academic impact, for papers by M Masuda Breakdown of academic impact, for papers by B.M. Dale Breakdown of academic impact, for papers by A. Berer Breakdown of academic impact, for papers by Debra Frei‐Lahr Breakdown of academic impact, for papers by Bishan S. Charak Breakdown of academic impact, for papers by Carole Maver
Rankless by CCL
2026